Nonsteroidal anti-inflammatory drugs are well-known culprits in the develop
ment of acute renal insufficiency in high-risk patients, The recent release
of the selective cyclooxygenase-2 enzyme inhibitors for the treatment of i
nflammatory diseases and pain syndromes has been associated with a clear-cu
t decrease in adverse gastrointestinal effects. However, the nephrotoxic po
tential of these agents in patients with prostaglandin-dependent states and
chronic renal impairment is unknown. Many clinicians commonly wonder if th
ese agents can be safely prescribed to such high-risk patients. We present
two cases of acute renal failure complicating the course of therapy with ce
lecoxib in patients with chronic renal insufficiency. (C) 2000 by the Natio
nal Kidney Foundation Inc.